Newsroom

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Cecile has served as interim Chief Financial Officer since August 16, 2026, steering the company’s financial operations, execution and strategic planning. “Cecile is an exceptional finance leader who knows our company and industry deeply, and she has a proven track record of opt...

PARIS--(BUSINESS WIRE)--Kbrw, spécialiste de l’orchestration et de l’exécution des flux supply chain, et Accenture (NYSE : ACN) ont été choisis par Orange pour transformer la gestion de ses commandes clients et de ses stocks sur ses canaux en ligne, dans ses boutiques et dans ses activités B2B. Ensemble, Kbrw et Accenture accompagnent Orange dans la mise en place d’un processus d’exécution des commandes plus fluide et plus réactif, au bénéfice de ses clients. La première phase du programme de d...

DUBLIN--(BUSINESS WIRE)--Intelligent power management company Eaton Corporation plc (NYSE:ETN) today reported strong third quarter 2026 results, including earnings per share of $2.77. Adjusted earnings per share were a record of $3.68, excluding charges of $0.62 per share related to intangible amortization, $0.30 per share related to acquisitions and divestitures, and income of $0.01 per share related to a multi-year restructuring program. Sales in the quarter were a record $8.9 billion, up 28%...

BOSTON--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced financial results for the second quarter of fiscal 2027 ended September 30, 2026. “Our Q2 results reflect continued top-line growth and strong operational efficiency,” said Rick McConnell, Chief Executive Officer, Dynatrace. “As organizations increasingly deploy AI agents into production, the need for enterprise-grade observability and governance has never been greater. By bringing Ariz...

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEssentia’s blood cancer treatment, ropeginterferon alfa-2b (Ropeg), has secured approvals for essential thrombocythemia (ET) in Taiwan, Japan, the United States, and China, widening treatment options for patients with the chronic disease. In Europe, however, the ET indication remains unapproved, underscoring the gap between clinical advances and patient access across global markets. Developed and manufactured by the Taiwan-based biopharmaceutical company P...

NEW YORK--(BUSINESS WIRE)--Academy Securities, the nation’s first Post-9/11 veteran owned and operated investment bank, today announced the addition of Kathryn Coulter Mitchell to its Geopolitical Intelligence Group. The Academy GIG consists of 45 US and UK Admirals & Generals, former NASA Astronauts, and former CIA/FBI Leadership. Academy has been advising clients for over a decade and is the preeminent Advisory on geostrategic risk to the markets. Kathryn Coulter Mitchell joins Academy af...

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop has arranged $109,900,000 in financing for Wyndchase Aspen Grove, a 560-unit multifamily community located in Franklin, Tennessee....

ROCHESTER HILLS, Michigan--(BUSINESS WIRE)--InfuSystem Announces Change in Third Quarter 2026 Earnings Release Date...

LONDON & JERSEY CITY, N.J.--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today reported the third quarter 2026 financial results and business highlights. "Compass is leading one of the most important advances in mental health care in decades. Millions of people living with TRD are waiting for new treatments that can deliver meaningful and lasting benefit, and we believe COMP360 ha...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today announced results for the third quarter ended October 3, 2026. Third-Quarter Financial Highlights Net sales of $1,614 million; year-over-year increase of 22.3% Net income of $164 million and net income per diluted share of $3.43 Non-GAAP diluted EPS increased year-over-year to $4.95 Adjusted EBITDA increased year-over...